Labcorp completes acquisition of select assets of Invitae

Labcorp (LH) announced the completion of its acquisition of select assets of Invitae (NVTA), a medical genetics company. Together, Labcorp and Invitae will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.